BofA Securities Upgrades BioNTech (BNTX) to Buy amid bullishness on mRNA-based pipeline

December 15, 2022 6:09 AM EST Send to a Friend
(Updated - December 15, 2022 9:22 AM EST)

BofA Securities analyst Tazeen Ahmad upgraded BioNTech (NASDAQ: BNTX) from Neutral ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login